Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
出版年份 2020 全文链接
标题
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
作者
关键词
-
出版物
DIABETOLOGIA
Volume 63, Issue 9, Pages 1808-1821
出版商
Springer Science and Business Media LLC
发表日期
2020-07-01
DOI
10.1007/s00125-020-05200-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic β-Cells
- (2019) Jamie R.J. Inshaw et al. DIABETES CARE
- KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
- (2019) Paradowska-Gorycka et al. Biomolecules
- Association between vascular endothelial growth factor receptor 2 rs11941492 C/T polymorphism and Chinese Han patients in rheumatoid arthritis
- (2019) Zhicheng Yang et al. MEDICINE
- Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides
- (2018) Tammy Price-Troska et al. INVESTIGATIONAL NEW DRUGS
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
- (2018) Michelle Rosenzwajg et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulatory T cells in the treatment of disease
- (2018) Amir Sharabi et al. NATURE REVIEWS DRUG DISCOVERY
- Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012
- (2017) Elizabeth J. Mayer-Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
- (2016) John A. Todd et al. PLOS MEDICINE
- Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes
- (2015) Aixin Yu et al. DIABETES
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- (2015) Michelle Rosenzwajg et al. JOURNAL OF AUTOIMMUNITY
- Insulin B chain 9–23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3 + T regs
- (2015) Mahzad Akbarpour et al. Science Translational Medicine
- Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
- (2014) A. A. Kennedy-Nasser et al. CLINICAL CANCER RESEARCH
- Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
- (2014) Michelle Rosenzwajg et al. Current Diabetes Reports
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
- (2013) Audrey Baeyens et al. DIABETES
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
- (2012) Teodora P. Staeva et al. DIABETES
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Administration of CD4+CD25highCD127- Regulatory T Cells Preserves -Cell Function in Type 1 Diabetes in Children
- (2012) N. Marek-Trzonkowska et al. DIABETES CARE
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune intervention in type 1 diabetes
- (2011) Aaron W. Michels et al. SEMINARS IN IMMUNOLOGY
- Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus
- (2010) Douglas O. Sobel et al. ACTA DIABETOLOGICA
- Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
- (2009) S. A. Long et al. DIABETES
- Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- (2009) Kajsa Wing et al. NATURE IMMUNOLOGY
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started